Series date: 
03/01/2019 - 8:00am to 12/31/2019 - 9:00am
DESCRIPTION
Mayo Clinic Arizona in collaboration with Arizona State University (ASU) faculty and students will utilize project ECHO to partner with selected providers throughout Arizona in order to improve the management of end stage liver disease and increase access to tertiary care hepatobiliary services. In addition to the case presentations and discussion, formal lectures on pertinent topics in liver diseases will be given and the slides will be made available on a website which will be available to all participants. 
 
TARGET AUDIENCE
Physicians, physicians assistants, nurse practitioners & RNs who may be treating patients with end stage liver disease
 

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:  

  1. Recognize the importance of  surveillance for hepatocellular carcinoma patients with end-stage liver disease
  2. Implement surveillance with every 6 months imaging patients with HCC
  3. Recognize the significance of a liver lesion in a patient with end stage liver disease 

ACCREDITATION STATEMENT


In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 


Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 ANCC nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed...

Relevent financial relationship(s) with industry: 
None

No relevent financial relationship(s) with industry: 
David Chascsa, MD; Rolland Dickson, MD; Karen Dobbins, MBA; Sydney Long; David Payton, PA-C; Lynn Ward, RN; George Welu; Adrienne White, MS

For disclosure information regarding Mayo Clinic School of Professional Development accreditation review committee member(s), please go here.

COURSE DIRECTOR
Rolland Dickson, MD
 

QUESTIONS?
Contact Sydney Long, Department Coordinator, at Long.Sydney@mayo.edu

Where did the idea for the course originate?: 
Arizona

Sessions

Session Date
End Stage Liver Disease TeleECHO 4/2/2019 04/02/2019 - 11:45am to 1:00pm
End Stage Liver Disease 4/30/19 04/30/2019 - 11:45am to 1:00pm
End Stage Liver Disease TeleECHO 5/14/19 05/14/2019 - 11:45am to 1:00pm
End Stage Liver Disease TeleECHO 5/28/19 05/28/2019 - 11:45am to 1:00pm
End Stage Liver Disease TeleECHO 10/1/19 10/01/2019 - 12:00pm to 1:00pm
End Stage Liver Disease TeleECHO 10/15/19 10/15/2019 - 12:00pm to 1:00pm
End Stage Liver Disease TeleECHO 10/29/19 10/29/2019 - 12:00pm to 1:00pm
End Stage Liver Disease TeleECHO 12/10/19 12/10/2019 - 12:00pm to 1:00pm
Liver Disease TeleECHO - SEE 2020 SERIES 04/28/2020 - 12:00pm to 1:00pm
Liver Disease TeleECHO - SEE 2020 SERIES 05/12/2020 - 12:00pm to 1:00pm

Pages